| Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone Therapy | Jan M. WIT,Asma DEEB,Bassam BIN ABBAS,Angham AL MUTAIR,Ekaterina KOLEDOVA,Martin O. SAVAGE | 329–340 |
| Novel Mutations in Obesity-related Genes in Turkish Children with Non-syndromic Early Onset Severe Obesity: A Multicentre Study | Ayşehan AKINCI,Doğa TÜRKKAHRAMAN,İbrahim TEKEDERELİ,Leyla ÖZER,Bahri EVREN,İbrahim ŞAHİN,Tarkan KALKAN,Yusuf ÇÜREK,Emine ÇAMTOSUN,Esra DÖĞER,Aysun BİDECİ,Ayla GÜVEN,Erdal EREN,Özlem SANGÜN,Atilla ÇAYIR,Pelin BİLİR,Ayça ERGÜR,OYA ERCAN | 341–349 |
| Glucose Metabolism Evaluated by Glycated Hemoglobin and Insulin Sensitivity Indices in Children Treated with Recombinant Human Growth Hormone | Maria Chiara PELLEGRIN,Daria MICHELON,Elena FALESCHINI,Claudio GERMANI,Egidio BARBI,Gianluca TORNESE | 350–357 |
| Impact of Socioeconomic Characteristics on Metabolic Control in Children with Type 1 Diabetes in a Developing Country | Abeer ALASSAF,Rasha ODEH,Lubna GHARAIBEH,Sarah IBRAHIM,Kamel AJLOUNI | 358–365 |
| Accuracy of Tri-ponderal Mass Index and Body Mass Index in Estimating Insulin Resistance, Hyperlipidemia, Impaired Liver Enzymes or Thyroid Hormone Function and Vitamin D Levels in Children and Adolescents | Neşe AKCAN,Rüveyde BUNDAK | 366–373 |
| Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis | Hatem Hamed ELSHORBAGY,Naglaa Fathy BARSEEM,Akram Elshafey ELSADEK,Ashraf Hamed AL SHOKARY,Yehia Hamed Abdel MAKSOUD,Sameh Elsayed ABDULSAMEA,Iman M. TALAAT,Hany Abdelaziz SULIMAN,Naglaa M KAMAL,Waleed E. ABDELGHANI,Sanaa Mohammed AZAB,Dalia Mohamed Nour EL DIN | 374–387 |
| Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia | Miłosz LOREK,Dominika TOBOLSKA LOREK,Barbara KALINA FASKA,Aleksandra JANUSZEK TRZCIAKOWSKA,Aneta GAWLIK | 388–394 |
| Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome | Małgorzata WOJCIK,Anna RUSZALA,Dominika JANUS,Jerzy B. STARZYK | 395–399 |
| Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China | Aijing XU,Jing CHENG,Huiying SHENG,Zhe WEN,Yunting LIN,Zhihong ZHOU,Chunhua ZENG,Yongxian SHAO,Cuiling LI,Li LIU,Xiuzhen Lİ | 400–409 |
| Subclinical Myocardial Dysfunction Demonstrated by Speckle Tracking Echocardiography in Children with Euthyroid Hashimoto’s Thyroiditis | Emine AZAK,Seyit Ahmet UÇAKTÜRK,İBRAHİM İLKER ÇETİN,HAZIM ALPER GÜRSU,Eda MENGEN,Utku PAMUK | 410–418 |
| A Novel Nonsense Mutation of PHF6 in a Female with Extended Phenotypes of Borjeson-Forssman-Lehmann Syndrome | Xia ZHANG,Yanjie FAN,Xiaomin LIU,Ming-Ang ZHU,Yu SUN,Hui YAN,Yunjuan HE,Xiantao YE,Xuefan GU,Yongguo YU | 419–425 |
| Isolated Growth Hormone Deficiency Type 2 due to a novel GH1 Mutation: A Case Report | Ahmad KAUTSAR,Jan M. WIT,Aman PULUNGAN | 426–431 |
| A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent | ŞÜKRAN POYRAZOĞLU,Vivian HWA,Andrew DAUBER,Ron ROSENFELD,FATMA FEYZA DARENDELİLER | 432–438 |
| A Case of Autosomal Dominant Osteopetrosis Type 2 with a CLCN7 Gene Mutation | Sol KANG,Young Kyung KANG,Jun Ah LEE,Dong Ho KIM,Jung Sub LIM | 439–443 |
| Three Siblings with Idiopathic Hypogonadotropic Hypogonadism in a Nonconsanguineous Family: A Novel KISS1R/GPR54 Loss-ofFunction Mutation | Özlem NALBANTOĞLU,Gülçin ARSLAN,Özge KÖPRÜLÜ,Filiz HAZAN,Semra GÜRSOY,BEHZAT ÖZKAN | 444–448 |
| Catch-up Growth at Term Equivalence in Extremely Premature Small for Gestational Age Infants Compared with Extremely Premature Appropriate for Gestational Age Infants | Hüseyin Anıl KORKMAZ | 449–450 |